This company has been marked as potentially delisted and may not be actively trading. HeartBeam (BEAT) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock BEAT vs. KRMD, AMWL, EUDA, LUNG, MDXH, CCLD, YI, IPA, PIII, and ZEPPShould you be buying HeartBeam stock or one of its competitors? The main competitors of HeartBeam include KORU Medical Systems (KRMD), American Well (AMWL), EUDA Health (EUDA), Pulmonx (LUNG), MDxHealth (MDXH), CareCloud (CCLD), 111 (YI), ImmunoPrecise Antibodies (IPA), P3 Health Partners (PIII), and Zepp Health (ZEPP). These companies are all part of the "medical info sys" industry. HeartBeam vs. Its Competitors KORU Medical Systems American Well EUDA Health Pulmonx MDxHealth CareCloud 111 ImmunoPrecise Antibodies P3 Health Partners Zepp Health KORU Medical Systems (NASDAQ:KRMD) and HeartBeam (NASDAQ:BEAT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment. Do analysts prefer KRMD or BEAT? KORU Medical Systems currently has a consensus target price of $4.50, suggesting a potential upside of 22.62%. HeartBeam has a consensus target price of $8.00, suggesting a potential upside of 519.67%. Given HeartBeam's higher probable upside, analysts clearly believe HeartBeam is more favorable than KORU Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score KORU Medical Systems 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00HeartBeam 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer KRMD or BEAT? In the previous week, KORU Medical Systems had 1 more articles in the media than HeartBeam. MarketBeat recorded 1 mentions for KORU Medical Systems and 0 mentions for HeartBeam. KORU Medical Systems' average media sentiment score of 1.67 beat HeartBeam's score of 0.00 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Overall Sentiment KORU Medical Systems Very Positive HeartBeam Neutral Do insiders and institutionals hold more shares of KRMD or BEAT? 58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 7.8% of HeartBeam shares are owned by institutional investors. 20.6% of KORU Medical Systems shares are owned by insiders. Comparatively, 18.0% of HeartBeam shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, KRMD or BEAT? KORU Medical Systems has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, HeartBeam has a beta of -0.7, suggesting that its stock price is 170% less volatile than the S&P 500. Is KRMD or BEAT more profitable? HeartBeam has a net margin of 0.00% compared to KORU Medical Systems' net margin of -15.09%. KORU Medical Systems' return on equity of -30.43% beat HeartBeam's return on equity.Company Net Margins Return on Equity Return on Assets KORU Medical Systems-15.09% -30.43% -19.41% HeartBeam N/A -358.33%-278.76% Which has stronger valuation & earnings, KRMD or BEAT? KORU Medical Systems has higher revenue and earnings than HeartBeam. KORU Medical Systems is trading at a lower price-to-earnings ratio than HeartBeam, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKORU Medical Systems$33.65M5.03-$6.07M-$0.11-33.36HeartBeamN/AN/A-$19.45M-$0.68-1.90 SummaryKORU Medical Systems beats HeartBeam on 12 of the 15 factors compared between the two stocks. Get HeartBeam News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BEAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BEAT vs. The Competition Export to ExcelMetricHeartBeamMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$43.95M$2.00B$5.52B$9.02BDividend YieldN/AN/A5.24%4.08%P/E Ratio-1.7435.1027.1920.04Price / SalesN/A11.80395.22100.83Price / CashN/A55.8726.2128.59Price / Book21.528.497.925.55Net Income-$19.45M-$62.39M$3.17B$248.49M HeartBeam Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BEATHeartBeam1.5865 of 5 stars$1.29-38.2%$8.00+519.7%-49.8%$43.95MN/A-1.741,700Gap UpKRMDKORU Medical Systems2.1792 of 5 stars$3.68+2.8%$4.50+22.3%+45.6%$169.80M$35.08M-33.4580News CoveragePositive NewsHigh Trading VolumeAMWLAmerican Well3.4631 of 5 stars$8.47-4.7%$9.67+14.1%+28.6%$132.22M$254.36M-0.831,040EUDAEUDA HealthN/A$3.42-4.5%N/A-11.4%$127.09M$4.01M0.002Gap UpLUNGPulmonx3.0025 of 5 stars$2.69+3.9%$11.53+328.4%-59.3%$108.30M$83.79M-1.87250MDXHMDxHealth1.5492 of 5 stars$2.12-4.1%$6.50+206.6%-8.5%$100.26M$90.05M-1.84300CCLDCareCloud2.2955 of 5 stars$2.27-3.8%$2.50+10.1%+11.3%$96.07M$110.84M-10.323,650Analyst DowngradeYI1110.6479 of 5 stars$7.11-0.4%N/A-26.2%$61.43M$1.97B-11.111,238Negative NewsIPAImmunoPrecise Antibodies2.512 of 5 stars$1.09+2.8%$4.00+267.0%+63.0%$49.88M$18.16M-0.9480News CoverageGap UpPIIIP3 Health Partners2.8938 of 5 stars$6.34+0.6%$16.25+156.3%-74.4%$45.59M$1.50B-0.13500ZEPPZepp Health3.0228 of 5 stars$2.82+6.1%$13.87+391.7%+38.2%$40.90M$182.60M-0.561,230 Related Companies and Tools Related Companies KORU Medical Systems Alternatives American Well Alternatives EUDA Health Alternatives Pulmonx Alternatives MDxHealth Alternatives CareCloud Alternatives 111 Alternatives ImmunoPrecise Antibodies Alternatives P3 Health Partners Alternatives Zepp Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BEAT) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartBeam, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartBeam With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.